Moderate Psoriasis

Immunology

Prevalence

3000.0 / 100K

Incidence

78.0 / 100K/yr

2 drugs in development·2 companies·1 clinical trial

Drug Pipeline by Phase

Compare drugs

Frequently asked questions

How many drugs are in development for Moderate Psoriasis?

BioSniper tracks 2 drugs in development for Moderate Psoriasis across 2 companies.

How many clinical trials target Moderate Psoriasis?

There are 1 clinical trial targeting Moderate Psoriasis tracked by BioSniper.

What is the prevalence of Moderate Psoriasis?

The estimated prevalence of Moderate Psoriasis is approximately 3000.0 per 100,000 population.

Deep-dive into Moderate Psoriasis

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Moderate Psoriasis — Drugs in Development & Clinical Trials | BioSniper